SD BIOTECHNOLOGIES

닫기

SD
BIOTECHNOLOGIES

GNB CLOSE

Balance Sheet

( Unit : million )

Balance Sheet
Item 2018 Y 12 M 2017 Y 12 M 2016 Y 12 M
Price Composition
ratio
Fluctuation
rate
Price Composition
ratio
Fluctuation
rate
Price Composition
ratio
Fluctuation
rate
TOTAL CURRENT ASSETS 83,632 55 15 % 72,749 57 75 % 41,444 61 51 %
TOTAL NON-CURRENT ASSETS 66,811 44 25 % 53,332 42 103 % 26,203 38 77 %
TOTAL ASSETS 150,442 100 19 % 126,081 100 86 % 67,647 100 60 %
TOTAL CURRENT LIABILITIES 21,149 14 72 % 12,230 9 9 % 11,137 16 9 %
TOTAL NON-CURRENT LIABILITIES 5,651 3 1247 % 419 0 -59 % 1,040 1 -32 %
TOTAL LIABILITIES 26,800 17 111 % 12,650 10 3 % 12,177 18 4 %
Capital stocks 11,208 7 1 % 11,032 8 17 % 9,432 13 300 %
Capital surplus 39,365 26 8 % 36,238 28 4508 % 786 1 -90 %
Retained earnings 73,025 48 12 % 65,143 51 46 % 44,625 66 121 %
TOTAL STOCKHOLDERS' EQUITY 123,642 82 9 % 113,431 90 104 % 55,470 82 82 %

Income Statement

( Unit : million )

Income Statement
Item 2018 Y 2017 Y 2016 Y
Price Fluctuation
rate
Price Fluctuation
rate
Price Fluctuation
rate
SALES(NET) 118,776 16 % 102,299 0 % 102,028 36 %
GROSS PROFIT 51,842 -5 % 54,848 -12 % 62,587 42 %
OPERATING INCOME 11,735 -55 % 26,499 -13 % 30,463 14 %
NON-OPERATING INCOME 1,971 37 % 1,432 18 % 1,212 62 %
NON-OPERATING EXPENSES 884 -49 % 1,732 235 % 517 -82 %
NET INCOME 10,892 -46 % 20,518 -16 % 24,451 33 %

Cash Flow Statement

( Unit : million )

Cash Flow Statement
Item 2018 Y 12 M 2017 Y 12 M 2016 Y 12 M
Price Fluctuation
rate
Price Fluctuation
rate
Price Fluctuation
rate
Cash flows from operating activities -15,171 -1374 % -1,029 -106 % 15,239 -31 %
Cash flows from investing activities -5,766 86 % -43,232 -208 % -14,005 40 %
CF from financing act. 19,026 -47 % 36,431 8261 % -446 -105 %
Increases(Decreases) in cash -1,911 75 % -7,830 -1094 % 788 -89 %
Cash at the beginning of the period 2,126 -78 % 10,097 8 % 9,316 468 %
Cash at the end of the period 215 -89 % 2,126 -78 % 10,097 8 %

※ 上述资料为财务报表基准